The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy.
about
A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivativesGenetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function.Potential role of UGT1A4 promoter SNPs in anastrozole pharmacogenomicsMethodologies used to identify and characterize interactions among antiepileptic drugs.Functional impact and prevalence of polymorphisms involved in the hepatic glucuronidation of valproic acid.Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.The pharmacogenomics of epilepsy.Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience.Influence of valproic acid concentration and polymorphism of UGT1A4*3, UGT2B7 -161C > T and UGT2B7*2 on serum concentration of lamotrigine in Chinese epileptic children.Association of UGT2B7 and UGT1A4 Polymorphisms with Serum Concentration of Antiepileptic Drugs in Children.Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: Influence of polymorphism of UDP-glucuronosyltransferases and drug transportersInterethnic differences in UGT1A4 genetic polymorphisms between Mexican Mestizo and Spanish populations.Pregnancy Increases Norbuprenorphine Clearance in Mice by Induction of Hepatic Glucuronidation.Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation.Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.Single-centre study of therapeutic drug monitoring of posaconazole in lung transplant recipients: factors affecting trough plasma concentrations.An investigation of the influence of patient-related factors and comedications on lamotrigine clearance in patients with epilepsy.Pharmacokinetics of lamotrigine in paediatric and young adult epileptic patients--nonlinear mixed effects modelling approach.Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients.
P2860
Q34125047-0C4D3684-592D-4CFA-9430-5853E4C130FFQ34273354-51A5FF2E-E031-4000-9BDA-D3AAE49B2688Q36717159-8E54CE9C-CAEE-470A-9558-B89FDE754888Q38018676-3947DF16-B4DE-4676-BC33-9A8E90AE4ECCQ38030052-4D9D940E-7D79-48B9-AE32-0E0E6376A445Q38181565-35D230F5-E7A4-43C0-B8DD-E98AD694E399Q38577986-E004D4E9-9FDC-4F6F-9F77-E8E7F75604FAQ39143986-26C811C8-619C-4017-BC16-B78AB8A9F474Q40577292-02D469BE-96ED-44CF-A496-48D848C245F4Q40612167-7EFF1E72-4FFC-4079-B963-DE365C524141Q42213046-F2501175-35AF-409B-ADCC-D63AD2308622Q42282801-AAA10551-4E62-48ED-8089-C76EE849BEF5Q46837567-191DA7B5-1B63-4623-80FF-A75EB32424AFQ47228852-C6068CB0-B7D4-49E7-8FF4-CC298960FDE5Q47384439-B4B00743-5DAF-4F3C-B58A-A215C3A3CE71Q50014381-B121B498-76E0-4F41-AA85-2A222925E172Q50049061-2D916091-9F31-4B44-89BF-C320748B0F5BQ50657925-4AE2C25F-29DC-4615-BB97-EDDC434D78D0Q51140860-ED271F23-FE6A-496E-B8E2-797DE1ECB037Q51285294-99BE80AF-E01D-4123-8D91-22FF112E3127
P2860
The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The relationship between UGT1A ...... ine in patients with epilepsy.
@ast
The relationship between UGT1A ...... ine in patients with epilepsy.
@en
type
label
The relationship between UGT1A ...... ine in patients with epilepsy.
@ast
The relationship between UGT1A ...... ine in patients with epilepsy.
@en
prefLabel
The relationship between UGT1A ...... ine in patients with epilepsy.
@ast
The relationship between UGT1A ...... ine in patients with epilepsy.
@en
P2093
P1433
P1476
The relationship between UGT1A ...... ine in patients with epilepsy.
@en
P2093
Aydan Ozkaynakcı
Cigdem Ozkara
Filiz Yılmaz Onat
Medine Idrizoglu Gulcebi
Mehmet Zafer Goren
Rezzan Gulhan Aker
P356
10.1016/J.EPLEPSYRES.2011.01.016
P577
2011-05-20T00:00:00Z